Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 21,039 | 16,123 | 14,562 | 13,840 | 12,431 |
| Operating Income | -21,039 | -16,123 | -14,562 | -13,840 | -12,431 |
| Other Income | 1,508 | 1,016 | 962 | 833 | 119 |
| Pre-tax Income | -19,531 | -15,107 | -13,600 | -13,007 | -12,312 |
| Net Income Continuous | -19,531 | -15,107 | -13,600 | -13,007 | -12,312 |
| Net Income | $-19,531 | $-15,107 | $-13,600 | $-13,007 | $-12,312 |
| EPS Basic Total Ops | -6.50 | -6.00 | -5.60 | -5.30 | -5.00 |
| EPS Basic Continuous Ops | -6.46 | -6.03 | -5.54 | -5.31 | -5.03 |
| EPS Diluted Total Ops | -6.50 | -6.00 | -5.60 | -5.30 | -5.00 |
| EPS Diluted Continuous Ops | -6.46 | -6.03 | -5.54 | -5.31 | -5.03 |
| EBITDA(a) | $-22,238 | $-16,852 | $-15,168 | $-13,965 | $-12,432 |